Quantcast
Last updated on April 16, 2014 at 12:38 EDT

Latest Carcinoma Stories

2013-02-05 08:28:16

BURLINGTON, Mass., Feb. 5, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the market for squamous cell carcinoma of the head and neck (SCCHN) in the United States and Europe will continue to face a high unmet need for targeted therapies aimed at specific subsets of patients, including those with human papillomavirus (HPV)-positive and Epstein-Barr virus (EBV)-positive disease....

2013-01-29 16:54:07

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative. The study cohort of 6,560 HIV-positive and almost 37,000 HIV-negative subjects was drawn from members of Kaiser Permanente Northern...

2013-01-29 12:27:17

BURLINGTON, Mass., Jan. 29, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the treatment landscape for hepatocellular carcinoma in the United States and Europe will change dramatically through 2021 as three new, potentially high priced therapies-Novartis's Afinitor, ArQule's tivantinib and Celsion's ThermoDox-arrive on the market, thereby greatly increasing treatment...

2013-01-29 08:31:10

OAKLAND, Calif., Jan. 29, 2013 /PRNewswire/ -- HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative. The study cohort of 6,560 HIV-positive and almost 37,000 HIV-negative subjects...

2013-01-09 09:53:52

Patients with non-small-cell lung cancer survive longer if they are taking beta-blockers while receiving radiotherapy, according to a study of 722 patients published in the cancer journal Annals of Oncology today (Wednesday). Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) reviewed the progress and outcomes of patients who had received radiotherapy as their main or first line of treatment for cancer (known as "definitive radiotherapy" i.e. radiotherapy that...

2012-12-26 08:20:56

WOONSOCKET, R.I., Dec. 26, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual Meeting in San Francisco, CA, on Tuesday, December 18. Simona Bot, M.D. presented preclinical research results in an abstract titled "Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma." This research was supported by MultiCell via a...

2012-11-30 16:11:11

A diagnosis of pancreatic cancer is particularly devastating since the prognosis for recovery is usually poor, with the cancer most often not detected until late stages. Research led by scientists at the University of California, San Diego and UC San Francisco Schools of Medicine examined the tumor-initiating events leading to pancreatic cancer (also called pancreatic ductal adenocarcinoma or PDA) in mice. Their work, published on line November 29 in the journal Cancer Cell, may help in...

2012-11-30 16:09:19

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors. The findings are published in the December 11 issue of the journal Cancer Cell. In 90 percent of cancer deaths, it is the...

2012-11-14 08:31:21

SAN DIEGO, Nov. 14, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announced positive interim results from a Phase IV trial investigating the use of NeoPulse in skin cancer patients at the 6th World Meeting of Interdisciplinary Melanoma/Skin Care Centres & 8th EADO Congress. Data from the trial showed a complete response of greater than 90 percent in basal cell...

2012-11-13 10:08:48

Those individuals who work outdoors with resultant sun exposure are at increased risk for non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Manigé Fartasch shows that the connection between occupational UV exposure and squamous cell carcinoma is now well-established in her review article in issue 43 of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2012; 109(43): 715–20). The results are less clear for basal cell...